Skip to content

This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device

Continuous Glucose Monitor (CGM) Discharge Program

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06965803
Acronym
CGM QOL
Enrollment
37
Registered
2025-05-11
Start date
2025-10-01
Completion date
2026-12-30
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.

Interventions

None listed

Sponsors

Cedars-Sinai Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* aged 18 or older * diagnosed with Type 1 or Type 2 Diabetes who are on insulin * able to speak and understand English language * scheduled to receive a standard inpatient diabetes education consultation * must not have used CGM in the six months prior to admission * owns a smartphone * demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program

Exclusion criteria

* those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices. * non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources/translations/personnel for evaluation and the education intervention that are not logistically possible right now.

Design outcomes

Primary

MeasureTime frameDescription
Patient Satisfaction (using a 5-point likert scale)15 daysGlucose Monitoring Satisfaction Survey

Countries

United States

Contacts

CONTACTMathew P Monterola, Doctor of Nursing Practice
Mathew.Monterola@cshs.org3109677434

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026